Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Warm numbing drops may speed up cataract surgery relief

NCT ID NCT07085481

First seen Dec 15, 2025 · Last updated Jun 22, 2026 · Updated 22 times

Summary

This study tested whether warming bupivacaine (a numbing drug) to body temperature before injecting it around the eye improves its effects for cataract surgery. 120 adults having cataract surgery received either room-temperature or warmed bupivacaine. Researchers measured how fast numbness started and how long it lasted. The goal is to see if a simple change—warming the medicine—can make the block work better and faster.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CATARACT are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Mansoura University

    Al Mansurah, 35511, Egypt

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

bupivacaine

What this could lead to

If warming bupivacaine works, it could make numbing for cataract surgery faster and longer-lasting, improving patient comfort during the procedure.

What could go wrong

This is a small, completed study with 120 participants. The effect may be small or not clinically meaningful, and results may not apply to other surgeries or anesthetics.

Conditions

The condition(s) this trial relates to.

cataract

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.